(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

As AI expands beyond the cloud into real-world devices, demand is accelerating for optimized, power-efficient neural processing architectures supporting both edge and hybrid AI models. This shift is ...

Incyte’s fourth quarter was met with a negative market reaction, despite the company delivering revenue growth above Wall ...

Truist Securities on Tuesday upgraded Shopify (NASDAQ:SHOP) to Buy from Hold and raised its price target to $150 from $110, arguing that a broad software selloff tied to AI concerns has created an ...